Alflutinib Mesylate

alflutinib · Allist Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alflutinib Mesylate, covering 2025-04-11 to 2025-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer （FLAG） [Phase 3]

See pricing